Medulloblastoma targeted therapy: From signaling pathways heterogeneity and current treatment dilemma to the recent advances in development of therapeutic strategies
- 12 September 2023
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 250, 108527
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Research of Jiangsu Higher Education Institutions of China (23KJB350003)
- National Natural Science Foundation of China (32301178)
- Natural Science Foundation of Jiangsu Province (BK20221045)
This publication has 220 references indexed in Scilit:
- Subgroup-specific structural variation across 1,000 medulloblastoma genomesNature, 2012
- Novel mutations target distinct subgroups of medulloblastomaNature, 2012
- Three decades of Wnts: a personal perspective on how a scientific field developedThe EMBO Journal, 2012
- A Mouse Model of the Most Aggressive Subgroup of Human MedulloblastomaCancer Cell, 2012
- An Animal Model of MYC-Driven MedulloblastomaCancer Cell, 2012
- Transventricular delivery of Sonic hedgehog is essential to cerebellar ventricular zone developmentProceedings of the National Academy of Sciences, 2010
- AGT-181: Expression in CHO cells and pharmacokinetics, safety, and plasma iduronidase enzyme activity in Rhesus monkeysJournal of Biotechnology, 2009
- The miR-17 ∼ 92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastomaProceedings of the National Academy of Sciences, 2009
- Identification of CD15 as a Marker for Tumor-Propagating Cells in a Mouse Model of MedulloblastomaCancer Cell, 2009
- Medulloblastoma Can Be Initiated by Deletion of Patched in Lineage-Restricted Progenitors or Stem CellsCancer Cell, 2008